Literature DB >> 20002023

Mechanisms of respiratory insufficiency induced by methadone overdose in rats.

Lucie Chevillard1, Bruno Mégarbane, Frédéric J Baud, Patricia Risède, Xavier Declèves, Donald Mager, Nathalie Milan, Ivan Ricordel.   

Abstract

Methadone may cause respiratory depression. We aimed to understand methadone-related effects on ventilation as well as each opioid-receptor (OR) role. We studied the respiratory effects of intraperitoneal methadone at 1.5, 5, and 15 mg/kg (corresponding to 80% of the lethal dose-50%) in rats using arterial blood gases and plethysmography. OR antagonists, including intravenous 10 mg/kg-naloxonazine at 5 minutes (mu-OR antagonist), subcutaneous 30 mg/kg-naloxonazine at 24 hours (micro1-OR antagonist), 3 mg/kg-naltrindole at 45 minutes (delta-OR antagonist) and 5 mg/kg-Nor-binaltorphimine at 6 hours (kappa-OR antagonist) were pre-administered. Plasma concentrations of methadone enantiomers were measured using high-performance liquid chromatography coupled to mass-spectrometry. Methadone dose-dependent inspiratory time (T(I)) increase tended to be linear. Respiratory depression was observed only at 15 mg/kg and characterized by an increase in expiratory time (T(E)) resulting in hypoxemia and respiratory acidosis. Intravenous naloxonazine completely reversed all methadone-related effects on ventilation, while subcutaneous naloxonazine reduced its effects on pH (P < 0.05), PaCO(2) (P < 0.01) and T(E) (P < 0.001) but only partially on T(I) (P < 0.001). Naltrindole reduced methadone-related effects on T(E) (P < 0.001). Nor-binaltorphimine increased methadone-related effects on pH and PaO(2) (P < 0.05) Respiratory effects as a function of plasma R-methadone concentrations showed a decrease in PaO(2) (EC(50): 1.14 microg/ml) at lower concentrations than those necessary for PaCO(2) increase (EC(50): 3.35 microg/ml). Similarly, increased T(I) (EC(50): 0.501 microg/ml) was obtained at lower concentrations than those for T(E) (EC(50): 4.83 microg/ml). Methadone-induced hypoxemia is caused by mu-ORs and modulated by kappa-ORs. Additionally, methadone-induced increase in T(E) is caused by mu1- and delta-opioid receptors while increase in T(I) is caused by mu-ORs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20002023     DOI: 10.1111/j.1369-1600.2009.00184.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  5 in total

1.  Mitragynine Attenuates Morphine Withdrawal Effects in Rats-A Comparison With Methadone and Buprenorphine.

Authors:  Rahimah Hassan; Cheah Pike See; Sasidharan Sreenivasan; Sharif M Mansor; Christian P Müller; Zurina Hassan
Journal:  Front Psychiatry       Date:  2020-05-07       Impact factor: 4.157

Review 2.  Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies.

Authors:  Amy Wachholtz; Gerardo Gonzalez; Edward Boyer; Zafar N Naqvi; Christopher Rosenbaum; Douglas Ziedonis
Journal:  Subst Abuse Rehabil       Date:  2011-08-18

3.  Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain.

Authors:  Camille Lagard; Lucie Chevillard; Karel Guillemyn; Patricia Risède; Jean-Louis Laplanche; Mariana Spetea; Steven Ballet; Bruno Mégarbane
Journal:  Pain       Date:  2017-03       Impact factor: 7.926

Review 4.  Modulation of Opioid Transport at the Blood-Brain Barrier by Altered ATP-Binding Cassette (ABC) Transporter Expression and Activity.

Authors:  Junzhi Yang; Bianca G Reilly; Thomas P Davis; Patrick T Ronaldson
Journal:  Pharmaceutics       Date:  2018-10-18       Impact factor: 6.321

5.  Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats.

Authors:  Rahimah Hassan; Sasidharan Sreenivasan; Christian P Müller; Zurina Hassan
Journal:  Front Pharmacol       Date:  2021-07-12       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.